Botswana Prospective Cancer Cohort

  • Principal Investigator(s): Scott Dryden-Peterson
  • Study Contact: Scott Dryden-Peterson, +2.677.447.2522, scott_peterson@post.harvard.edu
  • Description of Subjects: Botswana adults with a new diagnosis of cancer
  • Location (Domestic vs. International): Botswana Harvard AIDS Institute
  • Enrollment Period: 2010-ongoing
  • Enrollment Goal: 3000
  • Key Exclusion and Inclusion Criteria: cancer diagnosis, both HIV infected and HIV uninfected
  • Available Biological Specimens: N/A
  • How to Request Access: email study PI
  • Available Data Description: longitudinal outcome, baseline staging (CD4, VL)
See also: HIV+ and HIV-, Botswana Harvard AIDS Institute Partnership (BHP), Brigham and Women's Hospital, Studies > 1000 Participants, Studies Started Post-2005, International, Scott Dryden-Peterson, Cancer